CD95 is not functional in human erythrocytes

被引:8
|
作者
Sagan, D. [1 ]
Jermnim, N. [1 ]
Tangvarasittichai, O. [1 ]
机构
[1] Naresuan Univ, Fac Allied Hlth Sci, Phitsanulok 65000, Thailand
关键词
CD95; apoptosis; eryptosis; erythrocyte phosphatidylserine; exposure; PHOSPHATIDYLSERINE EXTERNALIZATION; APOPTOSIS; CELLS; MECHANISMS; EXPRESSION; ERYPTOSIS; CASPASE-3; LIGATION; PATHWAY; DEATH;
D O I
10.1111/j.1751-553X.2010.01245.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The CD95 pathway is a potent inducer of apoptosis in nucleated cells and this death receptor is important for proper blood cell development. Although it is expressed in red blood cells, its functional role in erythrocytes is not well documented. These anucleated cells can undergo cell death via eryptosis, a process showing similarities to apoptosis of nucleated cells. This mode of cell death is mainly triggered by oxidative stress or energy depletion. Methods: CH11 was added to the purified human erythrocytes for induction of phosphatidylserine (PS) exposure. AnnexinV-FITC was used as a probe for PS detection. Results: No significantly enhanced PS-positive cell fraction could be observed after erythrocytes were treated with CH11. Conclusion: Based on some key features for an activated CD95 system, this death receptor has been considered to induce PS exposure. However, we give evidence, that CD95 is not functional in red blood cells and that activation of this death receptor does not lead to the exposure of phosphatidylserine.
引用
收藏
页码:E244 / E247
页数:4
相关论文
共 50 条
  • [1] CD95 tyrosine phosphorylation is required for CD95 oligomerization
    Eberle, Andrea
    Reinehr, Roland
    Becker, Stephan
    Keitel, Verena
    Haeussinger, Dieter
    APOPTOSIS, 2007, 12 (04) : 719 - 729
  • [2] Interference of CD95 expression on human lymphocytes
    Petanova, J
    Fucikova, T
    Bencko, V
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2002, 204 (5-6) : 381 - 383
  • [3] CD95 in cancer: tool or target?
    Martin-Villalba, Ana
    Llorens-Bobadilla, Enric
    Wollny, Damian
    TRENDS IN MOLECULAR MEDICINE, 2013, 19 (06) : 329 - 335
  • [4] Effect of CD95 on inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes
    Li, Xiaoqiong
    Zhang, Zhanfeng
    Peng, Anping
    He, Min
    Xu, Jianhua
    Shen, Sujing
    Zhuang, Junhua
    Huang, Xianzhang
    CELLULAR IMMUNOLOGY, 2014, 290 (02) : 209 - 216
  • [5] CD95 tyrosine phosphorylation is required for CD95 oligomerization
    Andrea Eberle
    Roland Reinehr
    Stephan Becker
    Verena Keitel
    Dieter Häussinger
    Apoptosis, 2007, 12 : 719 - 729
  • [6] Death Induced by CD95 or CD95 Ligand Elimination
    Hadji, Abbas
    Ceppi, Paolo
    Murmann, Andrea E.
    Brockway, Sonia
    Pattanayak, Abhinandan
    Bhinder, Bhavneet
    Hau, Annika
    De Chant, Shirley
    Parimi, Vamsi
    Kolesza, Piotre
    Richards, JoAnne
    Chandel, Navdeep
    Djaballah, Hakim
    Peter, Marcus E.
    CELL REPORTS, 2014, 7 (01): : 208 - 222
  • [7] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [8] Apigenin Increases Natural Killer Cytotoxicity to Human Hepatocellular Carcinoma Expressing HIF-1α through High Interaction of CD95/CD95L
    Lee, Hwan Hee
    Cho, Hyosun
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2022, 32 (04) : 397 - 404
  • [9] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Tolomeo, M
    Dusonchet, L
    Meli, M
    Grimaudo, S
    D'Alessandro, N
    Papoff, G
    Ruberti, G
    Rausa, L
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (09) : 735 - 742
  • [10] CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression
    McCloskey, TW
    Oyaizu, N
    Bakshi, S
    Kowalski, R
    Kohn, N
    Pahwa, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 87 (01): : 33 - 41